CU20150065A7 - COMPOUNDS DERIVED FROM BENCIL 4 - ((2- (TRIAZOL-5-IL) ACETAMIDE) METHYL) PIPERIDIN-1- CARBOXYLATE ACTIVE AS AUTOTAXINE INHIBITORS - Google Patents
COMPOUNDS DERIVED FROM BENCIL 4 - ((2- (TRIAZOL-5-IL) ACETAMIDE) METHYL) PIPERIDIN-1- CARBOXYLATE ACTIVE AS AUTOTAXINE INHIBITORSInfo
- Publication number
- CU20150065A7 CU20150065A7 CUP2015000065A CU20150065A CU20150065A7 CU 20150065 A7 CU20150065 A7 CU 20150065A7 CU P2015000065 A CUP2015000065 A CU P2015000065A CU 20150065 A CU20150065 A CU 20150065A CU 20150065 A7 CU20150065 A7 CU 20150065A7
- Authority
- CU
- Cuba
- Prior art keywords
- inhibitors
- autotaxine
- bencil
- triazol
- piperidin
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 title 2
- DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- 102100021977 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Human genes 0.000 abstract 3
- 108050004000 Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 Proteins 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a nuevos compuestos que son inhibidores de autotaxina, procesos para su preparación, composiciones farmacéuticas y medicamentos que los contienen y a su uso en el tratamiento de una enfermedad o condición dependiente de ATX o mediada por ATX.The present invention relates to new compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and their use in the treatment of an ATX-dependent or ATX-mediated disease or condition.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361787796P | 2013-03-15 | 2013-03-15 | |
| PCT/IB2013/061047 WO2014097151A2 (en) | 2012-12-19 | 2013-12-17 | Autotaxin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20150065A7 true CU20150065A7 (en) | 2015-12-23 |
Family
ID=55177678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CUP2015000065A CU20150065A7 (en) | 2013-03-15 | 2015-06-19 | COMPOUNDS DERIVED FROM BENCIL 4 - ((2- (TRIAZOL-5-IL) ACETAMIDE) METHYL) PIPERIDIN-1- CARBOXYLATE ACTIVE AS AUTOTAXINE INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20150065A7 (en) |
-
2015
- 2015-06-19 CU CUP2015000065A patent/CU20150065A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20150326A (en) | AUTOTAXIN INHIBITORS | |
| MX2016014547A (en) | Compounds for treating spinal muscular atrophy. | |
| CL2016000952A1 (en) | Carboxamide derivatives and their use as medicines for the treatment of hepatitis b | |
| CL2015000295A1 (en) | Compounds derived from alkylpyrimidine; pharmaceutical composition that includes them; Use for the treatment of viral infections and other diseases. | |
| MX2020011449A (en) | OXYSTEROLS AND METHODS OF USE THEREOF. | |
| CL2018000542A1 (en) | New phenoxymethyl derivatives. | |
| CU20160007A7 (en) | DERIVATIVES OF 2 (((OXADIAZOL / TRIAZOL / TETRAZOL / ISOXAZOL) METHYL) PHENYL) -1- (HETEROCICLYL) -ONE AS ACTIVE AUTOTAXIN INHIBITORS | |
| CL2015000942A1 (en) | Compounds of substituted benzene. | |
| MX2017017008A (en) | NEW HYDROXIACIDE DERIVATIVES, A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| GT201500021A (en) | SULFAMOILARILAMIDAS AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B | |
| CL2015001864A1 (en) | Compounds derived from substituted spiropyrido [1,2-a] pyrazine, as hiv integrase inhibitors; pharmaceutical composition that includes them; and its use for the prophylaxis or treatment of a hiv infection. | |
| DOP2016000226A (en) | ISOINDOLINONE COMPOUNDS AS MODULATORS OF GPR119 FOR THE TREATMENT OF DIABETES, OBESITY, DISLIPIDEMIA AND RELATED DISORDERS | |
| UY35663A (en) | DERIVATIVES OF PIPERIDINIL-INDOL AS INHIBITORS OF COMPLEMENT FACTOR B AND USES OF THE SAME | |
| CO7160104A2 (en) | Hepatitis C virus inhibitors | |
| CL2012001959A1 (en) | Compounds derived from thiophene-2-carboxylic acid, flaviviridae virus inhibitors; pharmaceutical composition that includes them; and its use for the treatment of a viral infection by flaviviridae. | |
| MX2016001480A (en) | Formulation of syk inhibitors. | |
| MX2014005342A (en) | HEPATITIS VIRUS INHIBITORS C. | |
| MX2021005052A (en) | Oxysterols and methods of use thereof. | |
| GT201700023A (en) | OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES | |
| CR20160460A (en) | CONDENSED HETEROCICLES REPLACED AS MODULATORS OF GPR119 FOR THE TREATMENT OF DIABETES, OBESITY, DISLIPIDEMIA AND RELATED DISORDERS | |
| AR128459A2 (en) | ROLLER-COMPRESSED SOLID PHARMACEUTICAL COMPOSITION AND THE PROCESS FOR ITS MANUFACTURE | |
| UY35455A (en) | TRIPEPTIDIC INHIBITORS OF PROTEASA EPOXYCETONE | |
| NI201500096A (en) | CHEMICAL COMPOUNDS | |
| UY34775A (en) | USE OF LAQUINIMOD IN HIGH DOSE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
| PE20150167A1 (en) | (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL |